Cost-Effectiveness Of Ra Biologics In The Two Years Following Initiation Using A Validated Claims-Based Algorithm In A United States Commercially Insured Population
Abstract
Authors
M.M. Bonafede B.H. Johnson N. Princic N. Shah D.J. Harrison